Brief: Reg-Active Biotech Enters Into Global Patent License Agreement With Oncode Institute

Active Biotech AB publ

09/02/2022 08:32

Feb 9 (Reuters) - Active Biotech AB publ  ACTI.ST :
    * REG-ACTIVE BIOTECH ENTERS INTO GLOBAL PATENT LICENSE
AGREEMENT
WITH ONCODE INSTITUTE FOR TASQUINIMOD IN MYELOFIBROSIS
    * ACTIVE BIOTECH WILL PAY TO ONCODE INSTITUTE, CONTINGENT OF
MARKETING APPROVAL, MILESTONES AS WELL AS LOW SINGLE-DIGIT
ROYALTIES ON NET SALES

Source text for Eikon:  ID:nGNE7Dc29P 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))